Basketter David A, Andersen Klaus E, Liden Carola, Van Loveren Henk, Boman Anders, Kimber Ian, Alanko Kristiina, Berggren Elisabet
Applied Science and Technology, Safety and Environmental Assurance Centre, Unilever Colworth Laboratory, Sharnbrook, Bedford MK44 1LQ, UK.
Contact Dermatitis. 2005 Jan;52(1):39-43. doi: 10.1111/j.0105-1873.2005.00490.x.
The Technical Committee of Classification and Labelling dealing with harmonized classification of substances and classification criteria under Directive 67/548/EEC on behalf of the European Commission nominated an expert group on skin sensitization in order to investigate further the possibility for potency consideration of skin sensitizers for future development of the classification criteria. All substances and preparations should be classified on the basis of their intrinsic properties and should be labelled accordingly with the rules set up in the Directive 67/548/EEC. The classification should be the same under their full life cycle and in the case that there is no harmonized classification the substance or preparation should be self-classified by the manufacturer in accordance with the same criteria. The Directive does not apply to certain preparations in the finished state, such as medical products, cosmetics, food and feeding stuffs, which are subject to specific community legislation. The main questions that are answered in this report are whether it would be possible to give detailed guidance on how to grade allergen potency based on the existing methods, whether such grading could be translated into practical thresholds and whether these could be set for both induction and elicitation. Examples are given for substances falling into various potency groups for skin sensitization relating to results from the local lymph node assay, the guinea pig maximization test, the Buehler method and human experience.
代表欧盟委员会处理物质统一分类及《67/548/EEC指令》中分类标准的分类与标签技术委员会提名了一个皮肤致敏专家小组,以进一步研究在未来制定分类标准时考虑皮肤致敏剂效力的可能性。所有物质和制剂均应根据其固有特性进行分类,并应按照《67/548/EEC指令》规定的规则进行相应标签标注。在其整个生命周期内,分类应保持一致;若没有统一分类,物质或制剂应由制造商根据相同标准自行分类。该指令不适用于某些制成品状态的制剂,如医疗产品、化妆品、食品和饲料,这些产品受特定共同体法规约束。本报告回答的主要问题包括:是否有可能根据现有方法就如何对过敏原效力进行分级给出详细指导,这种分级是否能转化为实际阈值,以及是否能针对诱导和激发分别设定阈值。文中给出了与局部淋巴结试验、豚鼠最大化试验、比尤勒方法及人体经验结果相关的各类皮肤致敏效力组别的物质示例。